drugdeliverybusiness11h
SpyGlass Pharma shares positive data for drug-eluting intraocular lens
SpyGlass Pharma released 18-month follow-up data highlighting the potential of its (IOL)-based drug delivery platform.
drugdeliverybusiness1d
Ypsomed increases auto-injector production in Germany
Ypsomed announced today that it opened a new production hall at its German site in Schwerin to increase auto-injector ...
drugdeliverybusiness8d
Glooko announces CEO transition with $100M financing
Glooko announced today that it secured $100 million in a financing round and appointed Mike Alvarez as its new CEO.
drugdeliverybusiness11d
Trinity Biotech completes pre-pivotal study of next-gen CGM
Trinity Biotech today announced that it completed the first pre-pivotal clinical trial in Europe for its next-generation CGM ...
drugdeliverybusiness9d
Clearside Biomedical’s drug-device combo study meets endpoints
Clearside Biomedical today announced that the ODYSSEY study of its drug-device combination achieved its primary and secondary ...
drugdeliverybusiness11d
BD partners with ten23 health on prefilled syringe manufacturing
BD (NYSE:BDX) announced today that it entered into a collaboration with ten23 health to develop a new way to track ...
drugdeliverybusiness11d
Medinol has first human implant of drug-eluting peripheral stent in Australia
Medinol today announced the successful first-in-human implantation of its ChampioNIR drug-eluting peripheral stent.
drugdeliverybusiness9d
NIH launches effort to combat type 2 diabetes in young people
The National Institutes of Health (NIH) launched a nationwide consortium to address the rise in youth diagnosed with type 2 ...
drugdeliverybusiness17d
Qnovia wins FDA nod for nicotine inhaler as smoking cessation therapy
Qnovia’s nicotine replacement therapy device. [Image courtesy of Qnovia] Qnovia announced that the FDA cleared its investigational new drug (IND) application for the RespiRx smoking cessation inhaler ...